Detalhe da pesquisa
1.
CXCR2 inhibition enables NASH-HCC immunotherapy.
Gut
; 2022 Apr 27.
Artigo
Inglês
| MEDLINE | ID: mdl-35477863
2.
Expression of the B cell differentiation factor BAFF and chemokine CXCL13 in a murine model of Respiratory Syncytial Virus infection.
Cytokine
; 110: 267-271, 2018 10.
Artigo
Inglês
| MEDLINE | ID: mdl-29396045
3.
Cathelicidins Have Direct Antiviral Activity against Respiratory Syncytial Virus In Vitro and Protective Function In Vivo in Mice and Humans.
J Immunol
; 196(6): 2699-710, 2016 Mar 15.
Artigo
Inglês
| MEDLINE | ID: mdl-26873992
4.
Enteric helminth-induced type I interferon signaling protects against pulmonary virus infection through interaction with the microbiota.
J Allergy Clin Immunol
; 140(4): 1068-1078.e6, 2017 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-28196762
5.
Effector and central memory T helper 2 cells respond differently to peptide immunotherapy.
Proc Natl Acad Sci U S A
; 111(8): E784-93, 2014 Feb 25.
Artigo
Inglês
| MEDLINE | ID: mdl-24516158
6.
Combination peptide immunotherapy based on T-cell epitope mapping reduces allergen-specific IgE and eosinophilia in allergic airway inflammation.
Immunology
; 138(3): 258-68, 2013 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-23113712
7.
Neutrophil dynamics in the tumor microenvironment.
J Clin Invest
; 131(6)2021 03 15.
Artigo
Inglês
| MEDLINE | ID: mdl-33720040